Salah Eddine El Herrag

Ph.D. student in Cell Biology and Pathology

Nivolumab efficacy as cancer therapy: a metaanalysis of phase III randomized clinical trials


Conference paper


Salah Eddine El Herrag, Méghit Boumediène Khaled, Moulessehoul Soraya
13th Oncology Meeting Rabah Farhat, Algerian Soceity of Training & Research in Oncology and the Arab Medical Association Against Cancer , Sheraton Hotel, Algiers, 2021 Dec 16, pp. 38-39

View PDF 13th Oncolgy Meeting Rabah Ferhat
Cite

Cite

APA   Click to copy
Herrag, S. E. E., Khaled, M. B., & Soraya, M. (2021). Nivolumab efficacy as cancer therapy: a metaanalysis of phase III randomized clinical trials (pp. 38–39). Sheraton Hotel, Algiers: Algerian Soceity of Training & Research in Oncology and the Arab Medical Association Against Cancer .


Chicago/Turabian   Click to copy
Herrag, Salah Eddine El, Méghit Boumediène Khaled, and Moulessehoul Soraya. “Nivolumab Efficacy as Cancer Therapy: a Metaanalysis of Phase III Randomized Clinical Trials.” In , 38–39. 13th Oncology Meeting Rabah Farhat. Sheraton Hotel, Algiers: Algerian Soceity of Training & Research in Oncology and the Arab Medical Association Against Cancer , 2021.


MLA   Click to copy
Herrag, Salah Eddine El, et al. Nivolumab Efficacy as Cancer Therapy: a Metaanalysis of Phase III Randomized Clinical Trials. Algerian Soceity of Training & Research in Oncology and the Arab Medical Association Against Cancer , 2021, pp. 38–39.


BibTeX   Click to copy

@inproceedings{salah2021a,
  title = {Nivolumab efficacy as cancer therapy: a metaanalysis of phase III randomized clinical trials},
  year = {2021},
  month = dec,
  day = {16},
  address = {Sheraton Hotel, Algiers},
  organization = {Algerian Soceity of Training & Research in Oncology and the Arab Medical Association Against Cancer },
  pages = {38-39},
  series = {13th Oncology Meeting Rabah Farhat},
  author = {Herrag, Salah Eddine El and Khaled, Méghit Boumediène and Soraya, Moulessehoul},
  month_numeric = {12}
}


Share



Follow this website


You need to create an Owlstown account to follow this website.


Sign up

Already an Owlstown member?

Log in